Cognizant Technology Solutions
CTSH
$58.31
+1.11%
Cognizant Technology Solutions is a multinational IT services provider offering consulting, digital transformation, and business process outsourcing to enterprise clients across financial services, healthcare, and resources. As a major player in the global IT services industry, Cognizant leverages a cost-effective offshore delivery model, primarily from India, to compete with peers like Accenture and Infosys. The current investor narrative centers on the company's turnaround efforts under new leadership, focusing on AI-driven services and cost optimization, while navigating a challenging demand environment and a recent sharp stock price decline followed by a partial recovery.…
CTSH
Cognizant Technology Solutions
$58.31
Related headlines
Investment Opinion: Should I buy CTSH Today?
Rating: Hold. Cognizant is a hold because while the stock appears undervalued on a forward PE basis (9.02x) and has a Buy consensus with an average target of $64.10 (12.7% upside), the persistent negative price action and margin compression warrant caution. The thesis is that the company is in a turnaround phase, and if it can sustain the 5.83% revenue growth and stabilize margins, the stock could re-rate higher. However, the wide analyst target range and the PEG ratio of 20.57x indicate that the market is not fully convinced of the growth story.
Sign up to view all
CTSH 12-Month Price Forecast
The AI assessment is neutral with medium confidence. Cognizant's valuation is attractive on a forward PE basis, but the high PEG ratio and margin erosion temper enthusiasm. The stock's recent rebound of 29.47% over the past month suggests some positive momentum, but the longer-term trend remains bearish. To upgrade to a bullish stance, we would need to see sustained revenue growth above 6% and gross margin stabilization above 31%. Conversely, a downgrade to bearish would occur if revenue growth falls below 3% or if the stock breaks below $50. The key is whether the company can execute on its AI strategy and improve profitability.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Cognizant Technology Solutions's 12-month outlook, with a consensus price target around $63.94 and implied upside of +9.7% versus the current price.
Average Target
$63.94
0 analysts
Implied Upside
+9.7%
vs. current price
Analyst Count
—
covering this stock
Price Range
$42 - $84
Analyst target range
The target price range spans from a low of $42.00 to a high of $84.00, representing a wide spread of 100% between the low and high targets. This wide dispersion signals significant uncertainty about Cognizant's future performance, likely reflecting divergent views on the pace of AI adoption, margin recovery, and the ability to return to sustainable growth. The high target of $84.00 implies a 47.7% upside from the current price, suggesting that some analysts see substantial value if the company successfully executes its turnaround and benefits from AI-driven demand. Conversely, the low target of $42.00 implies a 26.2% downside, indicating that some analysts fear continued revenue pressure and margin erosion. The recent upgrade by Wedbush and the overall 'buy' consensus suggest a slight positive tilt, but the wide range highlights the high-risk, high-reward nature of the stock at current levels.
Bulls vs Bears: CTSH Investment Factors
Cognizant presents a classic value trap versus turnaround opportunity. The bull case rests on a reaccelerating revenue growth rate (5.83% YoY), a deeply discounted forward PE of 9.02x, and a solid balance sheet with low debt. However, the bear case is equally compelling, with a 19.75% annual stock decline, compressed gross margins, and a PEG ratio of 20.57x that suggests the market is not paying a bargain for growth. The most critical tension is whether the forward EPS estimate of $6.26 is achievable; if it is, the stock is significantly undervalued, but if margins continue to erode and growth stalls, the low forward PE could be a trap. Currently, the evidence slightly favors the bear case due to the persistent negative price action and margin pressure, but the low valuation and analyst support provide a floor. The resolution of this tension hinges on the company's ability to sustain revenue growth while stabilizing margins over the next few quarters.
Bullish
- Revenue growth reaccelerated to 5.83% YoY: Q1 2026 revenue of $5.413B grew 5.83% YoY, a clear inflection from the flat-to-declining trend seen in prior quarters (e.g., Q1 2025 revenue was $5.115B). This marks the first meaningful acceleration in years, signaling that the turnaround strategy is gaining traction.
- Forward PE of 9.02x is deeply discounted: The forward PE of 9.02x is significantly below the trailing PE of 18.20x and the sector average, implying the market is pricing in substantial earnings growth. With estimated EPS of $6.26 for the next fiscal year, the stock offers a compelling value proposition if the company can deliver on those estimates.
- Strong balance sheet with low leverage: Debt-to-equity is just 0.10x, and the current ratio is 2.34x, indicating ample liquidity and financial flexibility. This low leverage provides a cushion against operational headwinds and supports continued investment in AI and digital services.
- Analyst consensus is Buy with 12.7% upside: The average analyst target price is $64.10, implying a 12.7% upside from the current price of $56.89. With 25 analysts covering the stock and a recommendation mean of 2.17 (Buy), sentiment is constructive, and a recent upgrade by Wedbush adds to the positive tilt.
Bearish
- Stock down 19.75% over the past year: CTSH has underperformed the S&P 500 by a wide margin, with a 1-year price change of -19.75% versus +21.46% for the index. The stock sits at only 65.4% of its 52-week range, reflecting persistent selling pressure and a bearish long-term trend.
- Wide analyst target range signals high uncertainty: The analyst target price ranges from $42.00 to $84.00, a 100% spread, indicating deep disagreement about the company's future. This dispersion reflects uncertainty around AI adoption, margin recovery, and the sustainability of growth, making the stock a high-risk bet.
- Gross margin compressed to 29.6% in Q1 2026: Gross margin fell to 29.6% in Q1 2026, down from 33.6% in Q1 2025 and 35.1% in Q4 2024. This margin erosion suggests pricing pressure and rising delivery costs, which could limit earnings growth even if revenue improves.
- PEG ratio of 20.57x indicates overvaluation on growth: Despite a low forward PE, the PEG ratio of 20.57x is extremely high, implying that the market is paying a premium for the expected growth rate. This suggests that the low forward PE may be misleading, as it relies on aggressive EPS estimates that may not materialize.
CTSH Technical Analysis
Cognizant's stock has been in a pronounced downtrend over the past year, with a 1-year price change of -19.75%, significantly underperforming the S&P 500's +21.46% gain. The current price of $56.89 sits at 65.4% of its 52-week range (between $37.08 low and $87.03 high), indicating the stock is closer to its lows than highs, reflecting persistent selling pressure and a bearish long-term trend. The 6-month price change of -26.19% further underscores the severity of the decline, with the stock having lost over a quarter of its value in the past six months.
Beta
0.81
0.81x market volatility
Max Drawdown
-55.3%
Largest decline past year
52-Week Range
$37-$87
Price range past year
Annual Return
-16.2%
Cumulative gain past year
| Period | CTSH Return | S&P 500 |
|---|---|---|
| 1m | +37.0% | +2.4% |
| 3m | +22.2% | +4.7% |
| 6m | -17.8% | +11.7% |
| 1y | -16.2% | +21.3% |
| ytd | -28.3% | +13.4% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
CTSH Fundamental Analysis
Cognizant's revenue has shown a modest recovery, with Q1 2026 revenue of $5.413 billion, up 5.83% year-over-year, and a sequential increase from $5.333 billion in Q4 2025. This marks a return to growth after a period of stagnation, as revenue had been flat to slightly declining in prior quarters (e.g., $5.115 billion in Q1 2025). The growth is broad-based, with Financial Services contributing $1.644 billion and Healthcare $1.579 billion, but the company still faces headwinds from discretionary spending cuts in IT services. The 5.83% YoY growth rate is a positive inflection, but it remains below the double-digit growth rates seen in the pre-2023 era, suggesting a gradual recovery rather than a sharp rebound.
Quarterly Revenue
$5.4B
2026-03
Revenue YoY Growth
+5.8%
YoY Comparison
Gross Margin
29.6%
Latest Quarter
Free Cash Flow
$2.5B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is CTSH Overvalued?
Given that Cognizant is profitable, the PE ratio is the most appropriate valuation metric. The trailing PE is 18.20x, while the forward PE is 9.02x, a significant discount that implies the market expects substantial earnings growth (or a reversion to normalized earnings) in the coming year. The forward PE of 9.02x is notably low for a technology services company, suggesting the market is pricing in either a decline in earnings or a re-rating to a lower growth profile. The gap between trailing and forward PE (a 50% reduction) is unusually wide, which could indicate that the trailing earnings include one-time charges or that analysts expect a sharp recovery in EPS, as reflected in the estimated EPS of $6.26 for the next fiscal year.
PE
18.2x
Latest Quarter
vs. Historical
High-End
5-Year PE Range 11x~21x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
9.5x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks are significant. Cognizant's gross margin has declined from 35.1% in Q4 2024 to 29.6% in Q1 2026, a 5.5 percentage point drop, indicating pricing pressure and rising delivery costs. This margin compression could persist, especially if the company invests heavily in AI capabilities without immediate returns. The company's free cash flow is $2.47B TTM, which is positive, but the payout ratio of 27.4% and a dividend yield of 1.53% suggest limited room for dividend growth if cash flows weaken. Additionally, the wide gap between trailing PE (18.20x) and forward PE (9.02x) implies that the market expects a massive earnings jump, which may not materialize if revenue growth decelerates or margins continue to fall. The company's reliance on discretionary IT spending makes it vulnerable to economic downturns, and any slowdown in client budgets could derail the recovery.
FAQ
The key risks are: (1) Margin erosion, as gross margin has fallen from 35.1% in Q4 2024 to 29.6% in Q1 2026, which could continue and limit earnings growth; (2) Competitive pressures from AI-native companies and hyperscalers, which could disrupt the IT services industry; (3) Macroeconomic sensitivity, as the stock's beta of 0.809 indicates lower volatility, but a downturn could reduce IT spending; (4) Execution risk on the turnaround, as the stock has underperformed the market by 41.21% on a relative basis over the past year. The most severe risk is a failure to achieve the estimated EPS of $6.26, which would make the forward PE misleading and could lead to a de-rating.
The 12-month forecast is mixed, with a base case probability of 50% for a target range of $60-$68, aligning with the analyst average of $64.10. The bull case (25% probability) targets $70-$84, driven by successful AI adoption and margin recovery, while the bear case (25% probability) targets $42-$50, reflecting continued demand weakness and margin pressure. The most likely scenario is the base case, which assumes revenue growth of 4-6% and stable margins. The stock's recent 29.47% rebound over the past month suggests some positive momentum, but the longer-term trend remains bearish. Investors should monitor quarterly earnings for signs of improvement.
CTSH appears undervalued on a forward PE basis, trading at 9.02x versus a trailing PE of 18.20x, implying the market expects significant earnings growth. However, the PEG ratio of 20.57x suggests that the stock is overvalued relative to its growth rate, indicating that the low forward PE may be misleading. Compared to peers, the PS ratio of 1.89x is below the sector average, suggesting relative value. The market is pricing in a recovery, but the wide analyst target range (from $42 to $84) reflects uncertainty about the company's future. Overall, the stock is fairly valued to slightly undervalued, depending on whether the EPS estimates are achievable.
CTSH is a good buy for value investors with a medium-to-long-term horizon, given its low forward PE of 9.02x and analyst consensus Buy rating with an average target of $64.10, implying 12.7% upside. However, the stock has underperformed the market significantly, with a 1-year return of -19.75%, and faces margin pressures. The biggest downside risk is a fall to the 52-week low of $37.08, which would represent a 34.8% loss. Therefore, it is a good buy only if you believe the turnaround will succeed and are willing to accept the risk of further declines.
CTSH is more suitable for long-term investment, given its low forward PE and potential for a turnaround. The stock's beta of 0.809 indicates lower volatility than the market, but it has experienced significant drawdowns (max drawdown of -55.33%), making it risky for short-term trading. The company's dividend yield of 1.53% and payout ratio of 27.4% provide some income, but the growth prospects are uncertain. A minimum holding period of 2-3 years is recommended to allow the turnaround to play out and for the AI strategy to generate results. Short-term traders may find opportunities in the stock's volatility, but the fundamental case is better suited for patient investors.